• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Contact


Email

ksimpson@unimelb.edu.au

Credentials


Position
Honorary Conjoint Professorial Fellow
The Sir Peter MacCallum Department of Oncology
Education
PhD
La Trobe University
Bachelors Degree
Monash University
ORCID

0000-0001-9136-1781

Prof Kaylene Simpson

Honorary Conjoint Professorial Fellow
The Sir Peter MacCallum Department of Oncology

183 Scholarly works
17 Projects

HIGHLIGHTS

  • 2026

    Journal article

    Abstract 601: Translational reprogramming disrupts mitosis to drive SMAD4-deficient esophageal adenocarcinoma.
    DOI: 10.1158/1538-7445.am2026-601
  • 2026

    Journal article

    Discovery and Characterization of VPRBP/DCAF1 Kinase Inhibitor Analogs as Microtubular Destabilizing Agents with Potent Antimyeloma Activity
    DOI: 10.1158/1535-7163.MCT-25-0306
  • 2026

    Journal article

    Differential Preclinical Efficacy of Combined CDK4/6 and MEK Inhibition in Low-Grade Serous Ovarian Carcinoma Based on KRAS/NF1 Mutational Status
    DOI: 10.3390/ijms27041774
  • 2025

    Other

    Figure S1 from Distinct Assemblies of Heterodimeric Cytokine Receptors Govern Stemness Programs in Leukemia
    DOI: 10.1158/2159-8290.30859587
  • 2022

    Research grants (ARC, NHMRC, MRFF)

    Establishment of Novel, Neuronal-Cell Based, Therapeutic Screens for Alzheimer\2019s Disease Using Patients Stem Cells
  • 2020

    Research grants (ARC, NHMRC, MRFF)

    High Throughput Discovery of Synergistic Drug Combinations for Patients With Low-Grade Serous Ovarian Cancer
  • 2020

    Research Grant

    Translating Patient Stem Cells Into Personalised Screens for Age-Related Macular Degeneration
Kaylene Simpson

RECENT SCHOLARLY WORKS

  • 2025

    Other

    Figure S3 from Distinct Assemblies of Heterodimeric Cytokine Receptors Govern Stemness Programs in Leukemia
    DOI: 10.1158/2159-8290.30859581
  • 2025

    Other

    Figure S6 from Distinct Assemblies of Heterodimeric Cytokine Receptors Govern Stemness Programs in Leukemia
    DOI: 10.1158/2159-8290.30859572
  • 2025

    Other

    Supplementary Table S1 from Distinct Assemblies of Heterodimeric Cytokine Receptors Govern Stemness Programs in Leukemia
    DOI: 10.1158/2159-8290.30859566
  • 2025

    Other

    Figure S5 from Distinct Assemblies of Heterodimeric Cytokine Receptors Govern Stemness Programs in Leukemia
    DOI: 10.1158/2159-8290.30859575
  • 2025

    Other

    Figure S2 from Distinct Assemblies of Heterodimeric Cytokine Receptors Govern Stemness Programs in Leukemia
    DOI: 10.1158/2159-8290.30859584
  • 2025

    Other

    Figure S4 from Distinct Assemblies of Heterodimeric Cytokine Receptors Govern Stemness Programs in Leukemia
    DOI: 10.1158/2159-8290.30859578

RECENT PROJECTS

  • 2024

    Research grants (ARC, NHMRC, MRFF)

    OMIX3: High-Capacity Integrated Multi-Omics
  • 2023

    Research grants (ARC, NHMRC, MRFF)

    Repurposing Clinical Grade Medications for Treatment of Friedrich Ataxia Heart Disease

We acknowledge and pay respect to the Traditional Owners of the lands upon which our campuses are situated

Read about our commitment to reconciliation  

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia


View all Campus locations  
facebookIconlinkedinIconinstagramIcontwitterIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy  |  VaxFACTS

CRICOS number: 00116K     ABN: 84 002 705 224